Kevin Lee Freeman

HCAT

Kevin Lee Freeman serves as Chief Commercial Officer at Health Catalyst, Inc. (HCAT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$170.3K

Net Position

Net Seller

$170.3K

Companies Traded

HCAT

Active Period

Jun 2024 – Dec 2024

3 total trades

Most Recent

Sell HCAT

Dec 3, 2024 · $67.1K

Kevin Lee Freeman's Insider Trading at Health Catalyst, Inc. (HCAT)

Buys

0 · $0.00

Sells

3 · $170.3K

Total Shares Bought

Total Shares Sold

22,500

HCAT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 3, 2024	Sell	7,500	$8.94	$67.1K	236,950
Sep 5, 2024	Sell	7,500	$7.22	$54.2K	255,881
Jun 12, 2024	Sell	7,500	$6.53	$49.0K	266,153

Related Insiders

Simeon Kohl

director, officer: Chief Executive Officer

HCATBuy · Sep 16, 2026

Benjamin Landry

General Counsel

HCATSell · Dec 9, 2025

Julie Larson-Green

HCATSell · Dec 9, 2025

Explore More Insider Trading Data

HCAT Insider Trading Activity

View all insider trades at Health Catalyst, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity